Charles River Laboratories International Inc (CRL) EVP, Corp Strategy & Develop Joseph W ...

GuruFocus.com
·2 min read

- By insider

EVP, Corp Strategy & Develop of Charles River Laboratories International Inc (30-Year Financial, Insider Trades) Joseph W Laplume (insider trades) sold 8,735 shares of CRL on 02/25/2021 at an average price of $281.7 a share. The total sale was $2.5 million.


Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries. Charles River Laboratories International Inc has a market cap of $14.24 billion; its shares were traded at around $286.140000 with a P/E ratio of 39.73 and P/S ratio of 4.95. Charles River Laboratories International Inc had annual average EBITDA growth of 17.00% over the past five years. GuruFocus has detected 2 severe warning signs with Charles River Laboratories International Inc. .

CEO Recent Trades:

  • Chairman, President and CEO James C Foster sold 24,009 shares of CRL stock on 02/24/2021 at the average price of $284.75. The price of the stock has increased by 0.49% since.

  • Chairman, President and CEO James C Foster sold 37,731 shares of CRL stock on 02/23/2021 at the average price of $281.27. The price of the stock has increased by 1.73% since.

  • Chairman, President and CEO James C Foster sold 30,000 shares of CRL stock on 02/11/2021 at the average price of $285.02. The price of the stock has increased by 0.39% since.

CFO Recent Trades:

  • Corporate Executive VP & CFO David Ross Smith sold 8,656 shares of CRL stock on 02/19/2021 at the average price of $290.63. The price of the stock has decreased by 1.54% since.

Directors and Officers Recent Trades:

  • EVP, Corp Strategy & Develop Joseph W Laplume sold 8,735 shares of CRL stock on 02/25/2021 at the average price of $281.7. The price of the stock has increased by 1.58% since.

  • Director Stephen D Chubb sold 658 shares of CRL stock on 02/23/2021 at the average price of $281.66. The price of the stock has increased by 1.59% since.

  • Corporate Executive VP Birgit Girshick sold 1,675 shares of CRL stock on 02/19/2021 at the average price of $293.92. The price of the stock has decreased by 2.65% since.

  • CSVP&Chief Accounting Officer Michael Gunnar Knell sold 410 shares of CRL stock on 02/19/2021 at the average price of $290.99. The price of the stock has decreased by 1.67% since.

For the complete insider trading history of CRL, click here

.This article first appeared on GuruFocus.